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https://doi.org/10.1016/j.molcel.2020.07.001SUMMARYProtein kinases are essential for signal transduction and control of most cellular processes, including meta-
bolism, membrane transport, motility, and cell cycle. Despite the critical role of kinases in cells and their
strong association with diseases, good coverage of their interactions is available for only a fraction of the
535 human kinases. Here, we present a comprehensive mass-spectrometry-based analysis of a human ki-
nase interaction network covering more than 300 kinases. The interaction dataset is a high-quality resource
with more than 5,000 previously unreported interactions. We extensively characterized the obtained network
and were able to identify previously described, as well as predict new, kinase functional associations,
including those of the less well-studied kinases PIM3 and protein O-mannose kinase (POMK). Importantly,
the presented interaction map is a valuable resource for assisting biomedical studies. We uncover dozens
of kinase-disease associations spanning from genetic disorders to complex diseases, including cancer.INTRODUCTION
Reversible phosphorylation of serine, threonine, and tyrosine
residues represents a central molecular mechanism to control
key properties of proteins, including their enzyme activity, half-
life, complex formation, and subcellular localization. Phospho-
sites have been detected in almost all human proteins (Hornbeck
et al., 2015), and protein regulation by kinases is essential for
orchestrating the majority of biological processes in eukaryotes.
In the human genome, the protein kinase lineage tree encom-
passes more than 500 evolutionarily related proteins (Manning
et al., 2002; Wilson et al., 2018) (Table S1). These are organized
in 10 large families andmore than 100 subgroups.While a subset
of the kinases has been extensively characterized (e.g., those
belonging to the CMGC, STE, and RTK families), for many ki-
nases, we still only have a limited understanding of their func-
tional roles.
Kinases are strongly associated not only with cancer develop-
ment but also with Mendelian developmental disorders, meta-
bolic conditions (Lahiry et al., 2010), and different multifactorial
diseases. Together with GPCRs, they represent the main group
of current drug targets (Wang and Gray, 2015a, 2015b; Wu et al.,504 Molecular Cell 79, 504–520, August 6, 2020 ª 2020 The Authors
This is an open access article under the CC BY-NC-ND license (http://2015). For the understanding of cellular processes kinases
participate in, and consequently for the charting of associated
disease-relevant signaling pathways, it is critical to map kinase
interaction networks (Gstaiger and Aebersold, 2013). However,
at present, good coverage of protein interaction information is
available only for a subset of human kinases. A well-established
method for capturing stable protein interactions is affinity purifi-
cation coupled to mass spectrometry (AP-MS). Through orthog-
onal data integration and statistical analyses, AP-MS-generated
interaction data can be used to identify proteins that are involved
in the same cellular processes, protein complexes, or functional
and/or disease modules. In this context, we refer to a protein
complex as an assembly of proteins that stably interact with
each other as part of a single macromolecular entity and to a
module as interactors of the same bait protein that also share
a functional and/or disease association but that do not need to
be part of a single assembly (Chen et al., 2014).
Here, we performed a systematic AP-MS analysis of interaction
partners of human kinases. Our study has an unprecedented
depth and includesmore than 300 kinase baits representing all ki-
nase families, many of which have not been included in previously
published large-scale AP-MS studies (Hein et al., 2015; Huttlin. Published by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
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OPEN ACCESSResourceetal., 2015, 2017;Varjosaloet al., 2013), aswell asmore than5,000
previously unreported kinase interactions. This allowed us to
extensively characterize kinase regulation of physiological func-
tions and to define the biochemical context for several, as yet
poorly investigated protein kinases. This is exemplified by PIM3
and POMK kinases for which the identified interaction partners
predicted central roles in cytoskeleton regulationand the process-
ing of glycosylated proteins, respectively. For these two kinases,
we also validated interactions identified by AP-MS using orthog-
onal assayswithBioID-MSand reciprocal co-purification. Further,
using high-content imaging experiments, we could demonstrate
thatsomeof thepoorlycharacterizedkinases (NEK9andPKMYT1)
are required for cell shape control, which is consistent with their
preferred binding to proteins with roles in cytoskeletal organiza-
tion. In addition, we found multiple instances where interaction
neighborhoods of individual kinases were significantly enriched
in particular disease terms, including both Mendelian disorders
and multifactorial diseases. These findings are exemplified by
the nephronophthisis module associated with the NEK7 kinase
and proteins linked to schizophrenia around the PAK5 kinase.
Overall, this study represents themost comprehensive systematic
analysis of human kinase interactions to date and demonstrates
that the obtained network data are a highly valuable resource for
assisting functional studies of kinase complexes in health and dis-
ease. Interaction data can be searched via the following website:
https://sec-explorer.shinyapps.io/Kinome_interactions/.
RESULTS
Systematic Analysis of Human Kinase Interaction
Networks: Study Design and Scope
Building on an experimental workflow described previously, we
generated 316 cell lines, each expressing a specific epitope-
tagged kinase family member from a single locus under an
inducible promoter (Glatter et al., 2009) (Figure 1A). Selection
of the proteins used in the study was based on the feasibility to
detect the expressed kinase construct from each generated
cell line by AP-MS, and this excluded most membrane kinases.
To enhance detectability of sub-stoichiometric or weakly inter-
acting proteins, we used relatively large amounts of cellular start-
ing material (>108 cells) and a rapid single-step affinity purifica-
tion protocol (Figure 1A). We used a large set (n = 94) of
negative controls (i.e., cell lines expressing GFP; see STAR
Methods ) to facilitate subsequent data filtering. By comparing
receiver operating characteristic (ROC) curves of several estab-
lished filtering methods, we identified the combination of
weighted D (WD) score (Sowa et al., 2009) (see STAR Methods)
and protein abundance ratio compared to GFP control purifica-
tions as best performing, and we set the cutoff values such that
the number of false-positive interactions was kept below 1%
(see STAR Methods for details and additional data filtering).
Only 6% of the initial interactions passed these filtering criteria
(Figures S1A and S1B), and the filtering strategy also removed
a large number of typical AP-MS contaminant proteins from
the CRAPome database. The kinase baits used here cover 55
to 75% of kinase families members (Figure 1B) with the tyrosine
(Tyr) kinase family being the only exception. Overall, we identi-
fied 7,316 high-confidence interactions involving 2,379 uniqueproteins, with prey proteins being evenly distributed across ki-
nase families (Figure 1C; Table S2). Across all kinase families,
we identified between 66% and 93% novel interactions that
were not deposited in public protein-protein interaction (PPI) da-
tabases (Figure 1D). The number of identified interactors varied
significantly across individual kinases, but it was comparable
across kinase families (Figure 1C).
Data Quality and Novelty
The number of protein interactions reported in public databases
for individual kinases varies dramatically (Figure 2A). These dif-
ferences likely represent research bias toward heavily studied ki-
nases and proteins in general (Edwards et al., 2011). To assess
this, we investigated if the number of interaction partners per ki-
nase correlated with the number of studies that involved the
respective kinase. Even though poorly studied kinases (as deter-
mined by the number of citations in PubMed; Table S1) had on
average a significantly lower number of PPIs annotated in the
public databases compared to frequently studied kinases (Fig-
ure 2A), we observed no such differences in the connectivity in
the here-generated systematic AP-MS dataset, supporting the
unbiased character of our study. Of note, 90 of the kinases
used as baits here had 30 or fewer citations (Table S1).
In total, more than 150 baits included in this study have not
been assessed by previous large-scale AP-MS studies (Fig-
ure 2B), and 15% of the interactions have been already re-
ported in the PPI database Biological General Repository for
Interaction Datasets (BioGRID) (Figure 2C, top) (Stark et al.,
2006), a value that is comparable to other AP-MS studies. As a
measure of data robustness, we analyzed the number of inde-
pendent reports supporting the set of already known interac-
tions. We found that the fraction of known interactions reported
by at least two independent publications was greater than 50%
(Figure 2C, bottom). Overall, our repository confirms, as a single
resource, 1,236 PPIs reported in more than 800 publications.
Identification of Known and Putative Novel Protein
Modules and Complexes
Several previous interaction studies have shown that a strong
co-purification or joint detection of proteins across multiple baits
can indicate physical or functional association (Drew et al., 2017;
Knight et al., 2017; Youn et al., 2018). Using this principle, we
applied a hypergeometric test to identify protein pairs co-purify-
ing at significantly high frequency (see STAR Methods). We
found that many of the frequently co-purifying protein pairs
(1,718 protein pairs, i.e., 1% of all pairs, with adjusted p value <
0.01 and with at least five shared kinase baits) were indeed part
of larger protein complexes or functional modules (Table S3).
Pairs identified with a highly stringent cutoff (adjusted p value <
1010) are shown in Figure 2D. Several of these proteins be-
longed to complexes with well-annotated roles in the regulation
of kinase stability and activity, such as HSP90-CDC37 and stria-
tin-interacting phosphatase and kinase (STRIPAK) complexes,
respectively. Among others, the analysis highlighted several
groups of co-purifying proteins with distinct roles in carbon
metabolism or rRNA and mRNA processing, as well as proteins
from stable complexes. The latter included mitochondrial com-




Figure 1. Systematic Mapping of Kinase Interactions by AP-MS
(A) Workflow used to generate the kinase interaction network. This includes generation of more than 300 cell lines stably expressing doxycycline-inducible ki-
nases, single-step pull-downs, duplicate runs on a hybrid linear ion trap-Orbitrap mass spectrometer, peptide identification with X!Tandem, and statistical
evaluation.
(B) Coverage of kinases across different families. Dark blue represents included and orange not included kinases.
(C) Distribution of the number of identified interactors per kinase.
(D) Novel versus known interactions for each kinase family are plotted against the kinome evolutionary tree. Each kinase family is represented with a different
color, and the same coloring scheme is used in all figures.
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OPEN ACCESS Resourcechaperonin complex, and the less well-studied BCLAF1-
THRAP3 protein complex with a role in DNA damage response
(Vohhodina et al., 2017) (Figure 2D). The identified modules of506 Molecular Cell 79, 504–520, August 6, 2020co-purifying proteins can also assist protein functional assign-
ments. An example is the less well-studied FTSJ3 protein (Ring-
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OPEN ACCESS Resourcemethyltransferase. We found that FTSJ3 co-purified (p value <
105) with several proteins involved in rRNA processing (Fig-
ure 2D; Table S3), which corroborated its suggested function.
The strongest hit in the co-purification analysis was the HSP90
chaperone complex (composed of HSP90A, HSP90B, and
CDC37 proteins). This complex is highly expressed and its
core components are often considered contaminants in AP-
MS studies. However, 60% of all kinases are known to be cli-
ents of the heat shock protein (HSP) complex (Taipale et al.,
2012; Verba et al., 2016). We reasoned that we could use reten-
tion/exclusion patterns of this complex across the baits in this
study to evaluate the specificity of our pull-downs and filtering.
For this, we compared our results with the extensive biochemical
characterization of HSP90-kinase interactions carried out by Tai-
pale and colleagues (Taipale et al., 2012). In their work, they
could distinguish between kinases that are strongly or weakly
associated with HSP90. We found that our data were in very
good agreement with their results; the majority of the kinases
previously classified as strong interactors of the HSP90 complex
members were present in our pull-downs. In contrast, this was
the case only for a smaller percentage of the weak interactors
and a minor fraction of the noninteractors (Figure 2E; Table
S4). These results thus support the filtering strategy em-
ployed here.
Next, we benchmarked the kinase interaction network against
the manually annotated core protein complexes deposited in the
comprehensive resource of mammalian protein complexes (CO-
RUM) database (core complexes, release 02.02.2017) and in this
way assessed the integrity of kinase-containing complexes.
Overall in our set, we could retrieve 50%–100% of the compo-
nents for about 50% of the kinase-containing CORUM com-
plexes, with several instances of kinases bound to their adap-
tors/accessory subunits (e.g., PKA, CK2, and IKK), or within
their stable complexes, such as the EVDP, as illustrated in Fig-
ures 2F and S1C. In a comparison to randomized kinase net-
works (see STAR Methods), the overlap between the CORUM
and our interactions was highly significant (Figure 2G). To further
validate that we are able to capture stable interactions among ki-
nases and associated protein complexes, we compared PPIs
from the kinase interaction network to correlation profiling data
generated from size-exclusion chromatography (SEC) experi-
ments in our laboratory (Heusel et al., 2019). Our analysis indeedFigure 2. Assessment of the Network Scope and Data Quality
(A) Barplot depicting the number of interactions per kinase found in public datab
(blue bars). A running average of the number of citations per kinase is shown as a re
(B) Venn diagram shows an overlap between kinase baits used in our study and
BioPlex 2 (Huttlin et al., 2017).
(C) Fraction of all protein interactions detected in different AP-MS studies that we
The number of citations associated with the recapitulated interactions is also sh
(D) Protein pairs that were almost exclusively purified together with different kina
(E) Stacked barplots show the fraction of the HSP90 chaperone complex memb
strong or weak clients or were not identified as HSP90 clients (Taipale et al., 201
(F) Representative kinase-containing CORUM complexes that were recapitulated
more than 75% of complex subunits covered.
(G) Contacts between CORUM protein pairs in the kinase network are enriched
pology.
(H) Distribution of co-elution correlation values for all protein pairs measured in HE
for protein pairs found in the same CORUM complex (dark blue area) or here in the
508 Molecular Cell 79, 504–520, August 6, 2020showed that the here-identified interaction pairs had significantly
higher SEC co-eluting values than randomprotein pairs (i.e., they
were often found physically associated in an independent assay)
(Figure 2H).
Together, these results support the organization of the kinase
interaction network in well-defined functional units and addition-
ally show that co-purification patterns can be effectively used to
suggest new functional associations.
Functional Landscape of the Human Kinase Interaction
Network
To explore the functional space occupied by different kinases,
we first analyzed Gene Ontology (GO) terms associated with ki-
nases and their interaction partners. GO analysis at the kinase
family level lacked specificity, so we focused on the analysis of
GO term enrichment among the interactors of evolutionarily
more strongly related kinase subgroups. The thus-identified sig-
nificant GO terms defined subgroup-specific functional finger-
prints and indicated that processes could be broadly partitioned
in those controlled by several different kinase subfamilies (such
as cell cycle, protein transport, and apoptosis) and those primar-
ily regulated by a single or low number of kinase subfamilies
(such as a mRNA splicing, circadian rhythm, and specialized
signaling pathways; Figures 3A and S2A). To determine to
what extent our data recapitulated already established func-
tional knowledge and revealed novel functional associations,
we used a semantic similarity score (Yu et al., 2010). Using this
score, which measures similarity between groups of GO terms,
we compared the most significant GO terms obtained in this
analysis with the GO terms of the known interaction partners of
the same kinase (obtained from the public repository Integrated
Interaction Database [IID]; see STAR Methods). For several ki-
nase subfamilies (e.g., casein kinase I, mitogen-activated protein
kinase [MAPK], IKK, Aurora, Polo, and STE20), we found a strong
functional match between prior knowledge and our results, sug-
gesting that the newly discovered interactions confirm and
expand our knowledge of the kinase activities in previously
defined contexts (Figure 3B).
In addition, our GO analysis suggested a better definition of
the biochemical roles for several less well-studied subfamilies
and specific kinases. This is illustrated by the proteins interact-
ing with PIM3 kinase (Figure 3C). PIM3 is the least-studiedases (http://dcv.uhnres.utoronto.ca/iid/; gray bars) and in the presented study
d line. Bars are ordered by the decreasing number of interactions based on IID.
baits used in two previous large-scale AP-MS studies: Hein et al. (2015) and
re also reported by additional studies deposited in the BioGRID database (top).
own (bottom).
se baits (p value < 1010) are shown.
ers found here as interactors of kinases that were previously classified as its
2).
in the generated network. Conditions for this were more than two subunits and
in a comparison to 500 reshuffled networks of the same composition and to-
K293 SEC analysis (Heusel et al., 2019) (gray area). Average correlation values
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OPEN ACCESS Resourcemember of the PIM subfamily of CAMK kinases. As of January
2020, only four interactions were reported in the IID PPI data-
base (Kotlyar et al., 2016) and only one in BioGRID (Stark
et al., 2006). The PIM family has been implicated in the progres-
sion of several malignancies, possibly through regulating cell
motility. PIM3 itself was linked to a decreased survival in pros-
tate cancer patients (Santio and Koskinen, 2017). In line with
these observations, the PIM3 interactors identified in this study
included five different proto-oncogenic SRC kinases (FYN,
LYN, SRC, YES1, and FRK) as well as subunits of heterotri-
meric G proteins. In addition, our study revealed a strong asso-
ciation of PIM3 with cytoskeletal proteins, in particular several
actin-regulating modules, with an interaction pattern compara-
ble to that observed for the cytoskeletal kinase DAPK1. To
confirm the PIM3 association with cytoskeletal proteins, we
tagged separately N- and C- terminus of PIM3 with the biotin
ligase Flag-BirA* and carried out a proximity labeling experi-
ment, BioID coupled to MS, in an orthogonal cell line, HeLa
CC2, using a doxycycline-inducible system. We found that
cytoskeleton-related GO terms were also overrepresented in
the thus-defined PIM3 proximal proteome (Figure S2B). While
the overlap between AP-MS and BioID-MS was relatively low
(as expected from the different chemistries and lysis conditions
the two methods use and in accordance with previous reports;
Lambert et al., 2015), the large majority of the proteins found by
both AP-MS and BioID-MS were indeed cytoskeletal, thus
independently confirming the initial finding (Figure S2C). By
this means, our data also suggest possible routes for the
PIM3 control of cell shape and motility.
Besides PIM3, we found that several other poorly studied ki-
nases (with less than 50 citations) preferentially associated with
proteins linked to cell shape related GO terms (Table S5). To
test whether these kinases are indeed functionally linked to cell
shape control, we subjected them to small interfering RNA
(siRNA)-mediated knockdown and subsequent high-content im-
age-based profiling of cell shape phenotypes in two cell lines
(LN229 and SKOV3). Our results revealed that several of the
tested kinases (in particular NEK9 and PKMYT1/MYT1) were
indeed necessary for controlling cell shape (Figures 3D, S2D,
and S2E). Both genes, as well as several other kinases with
positive phenotypes, are known to play a role in cell-cycle regula-
tion. Therefore, additional experiments are needed to determine
whether the identified cell shape changes in the kinase-knock-
down cells result from a direct involvement of these kinases in
controlling cell shape or indirectly via affecting cell-cycle control.Figure 3. Functional Landscape of the Kinase Interaction Network
(A) Dotplot of the most significant terms associated with kinase subgroups cove
(B) Semantic similarity between the top GO terms based on the interactions from
(C) Main associations in the PIM3 interaction network include the actin cytoskele
(D) Cellular phenotyping after gene silencing. Volcano plot depicts siRNA gene ta
shape phenotypes relative to the negative siRNA control. Targets that had alog1
different features measured, as defined by the CellProfiler software tool. Differen
siRNAs are denoted by the symbol ‘‘|’’. Heatmaps summarize the information on
nificant.
(E) Circos plot of all kinase-kinase interactions. Coloring scheme is the same as
(F) Ratio between intra-family and inter-family connections.
(G) Number of kinases versus total number of interactors per kinase bait.
(H) WNK3 kinase hub with its interactors and known associations with the endoc
510 Molecular Cell 79, 504–520, August 6, 2020The Kinase-Kinase Interaction Network
Consistent with the notion that kinases preferentially bind other
kinases (Breitkreutz et al., 2010; Colinge et al., 2014), we found
that ‘‘kinase’’ was the most significantly enriched domain among
the proteins associated with the tested baits. This corresponds
to 454 kinase-kinase contacts (i.e., 5% of all observed interac-
tions) (Figure S2F; see STAR Methods). Overall, more than 250
of these kinase-kinase interactions were not reported previously.
To better understand the architecture of these associations, we
represented all kinase-kinase contacts as a circos plot (Fig-
ure 3E). This highlighted a strong interconnectivity among ki-
nases that belong to the same families. The highest degree of
intra-family connectivity was among kinases from small kinase
families, such as CK1 and NEK, and among kinases from the
larger STE family (Figure 3F). At the other end of the spectrum,
the highest frequency of inter-family connections was observed
for the tyrosine like-kinases (TKLs) and for kinases not assigned
to any of the families and therefore classified as ‘‘other.’’ Of note,
the number of kinase-kinase interactions did not correlate with
the total number of interactions per kinase (Figure 3G).
This analysis also highlighted several new kinase hubs
(defined here are kinases that interacted with three or more other
kinases). An example for this is theWNK3 kinase (Figure 3H). The
WNK3 interactors included its two homologs, WNK2 andWNK1,
as well as four other kinases, STK39, PIK3, GAK, and BIKE.
WNKs have been previously shown to regulate the surface
expression of ion transporters by a variety of means, including
endocytosis (WNK1/4) and activation of STK39. Besides the
known interaction with STK39 (McCormick and Ellison, 2011),
WNK3 was associated with several components of the endo-
cytic machinery. Interestingly, BIKE, GAK, and PIK3 have also
been previously reported to interact with endocytosis regulators,
and the activation of PIK3 was shown to be required for the
WNK1-mediated regulation of the potassium channel ROMK
endocytosis (Cheng and Huang, 2011), suggesting that, similar
to WNK1, WNK3 may also be involved in the endocytosis of
ion transporters.
Importantly, besides interactions among kinases, hundreds of
new interactions with other proteins involved in cellular regula-
tion, such as phosphatases, E3 ubiquitin ligases, DUB enzymes,
and epigenetic factors, were identified in the study (Figures
S2G–S2J). In particular, a large fraction of the kinase interactions
with epigenetic factors was not previously deposited (Fig-
ure S2H). In summary, our analysis provides the first systematic
insight into the global organization of inter-kinase relationships inred in this study.
this study and interaction partners deposited in the IID.
tal and G proteins and SRC modules.
rgets that displayed the strongest changes in the representative cell area and
0 (p value) greater than 2.5 are labeled with their gene names. Colors represent
t siRNAs for the same gene are indicated with 1 or 2, and combinations of
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OPEN ACCESS Resourcehuman cells and suggests wide a biochemical context for kinase
regulatory activity in controlling protein phosphorylation, ubiqui-
tylation, and gene expression.
The Kinase Interaction Network as a Valuable Resource
for Mapping Kinase-Substrate Relationships
By now, more than 200,000 phosphoresidues in the human pro-
teome have been cataloged (Hornbeck et al., 2015). However,
for only a small fraction of these are the kinases catalyzing the
phosphorylation event known (Wagih et al., 2016). We therefore
investigated if the interaction dataset generated here could be
used to nominate kinase-substrate assignments. We found
that 75 of the physical interactions in our dataset were previously
reported as kinase-substrate pairs. To determine the signifi-
cance of this observation, we generated a set of 1,000 random
networks that mirrored the kinase interaction network size and
topology and assessed the number of known kinase-substrate
interactions in these networks (see STAR Methods). There, the
mean number of interactions documented as a regulatory event
was 16 (Figure 4A). Hence, the observed 75 kinase-substrate in-
teractions represented a strong enrichment (p value < 1053) and
indicated that the generated network likely included instances of
kinases bound to their substrates.
Next, we aimed to predict novel kinase-substrate relationships
in our dataset (Figure 4B). For this, we used the NetPhorest tool
(Miller et al., 2008) and considered thus-identified kinase motifs
around the experimentally confirmed phosphoresidues (i.e.,
sites identified in five or more large-scale studies or a single tar-
geted small-scale study; Hornbeck et al., 2015)). We restricted
our analysis to the top three kinase families predicted to be
able to recognize each phosphosite (see STAR Methods). In to-
tal, we found 550 instances where computationally predicted ki-
nase-substrate directional interactions were also supported by a
physical contact in the generated kinase interaction network
(Figure 4C; Table S6). This overlap, which consisted of 534
nondirectional protein interactions (16 interactions corre-
sponded to reciprocal kinase-substrate relationships), repre-
sented a significant enrichment when compared to a set of
1,000 random networks of the same size and topology (mean
of 394, p < 1016; Figure 4C). Collectively, for the phosphosites
included in the analysis, this increases the fraction of sites with
an upstream kinase assignment from 15% to 26%.
Since AP-MS largely captures stable interactions, we as-
sessed if any of the bait kinases were predicted to regulate
two or more proteins from the same CORUM complex (RueppFigure 4. Kinase Interaction Network Assists Assignments of Regulato
(A) In the generated kinase network, 75 interactions (red arrow) were known kinas
random networks (shown as a histogram on the left).
(B) Criteria for the prediction of novel kinase-substrate relationships.
(C) In total, 534 interactions in the kinase network were predicted as possible k
average number of predicted pairs in random networks (histogram on the left).
(D) Several substrate proteins predicted to be regulated by casein kinase 2 form
depicted with red and gray arrows, respectively. Dashed lines indicate connection
holoenzyme is a tetramer with two CK2b regulatory subunits and CK2a1 and CK
(E) CK2 predicted substrates with more than five CK2 phosphomotifs are shown
were reported as CK2 substrates in previous studies are indicated in dark red.
(F) Kinase-kinase regulatory interactions occur within and across kinase familie
colored in green represent activation loop phosphorylation. Kinase families are c
512 Molecular Cell 79, 504–520, August 6, 2020et al., 2008). This highlighted the CK2 a2/b2 holoenzyme (Fig-
ure 2F) as a possible regulator of multiple subunits from epige-
netic complexes and the splicing machinery (Figure 4D; see
also Figure S2J). Importantly, several of these proteins were
already known substrates of the CK2 CSNK2A1/CK2a1 kinase.
In addition to this, CK1 kinases were identified as possible regu-
lators of smaller complexes involved in transcriptional elongation
(Figure S3A).
Many of the proteins annotated as known CK2 substrates
contain multiple phosphosites that can be recognized by this
complex (Shi et al., 2009; Wise et al., 1997; Yang et al., 2013).
In line with this, 20 of the proteins that we predicted as
CSNK2A1/CK2a1 and/or CSNK2A2/CK2a2 substrates had six
or more confident phosphosites (defined as above) that mapped
within sequence motifs that can be recognized by CK2 (Fig-
ure 4E). None of these 20 proteins were among the known CK2
substrates deposited in PhosphoSitePlus (Hornbeck et al.,
2015). However, CK2 kinase regulation of several chromatin
modifiers, which we predict here, has actually been reported
by previous individual studies. These instances include HIRIP3
(Assrir et al., 2007), DEK (Kappes et al., 2004), SMARCA4 (Pa-
dilla-Benavides et al., 2017), and TCOF1 (Ciccia et al., 2014;
Wise et al., 1997) proteins. In addition to CK2 substrates, pre-
dicted substrates of CLK2 and CLK3 splicing regulators also
had multiple phosphomotifs, which could be recognized by
these kinases (Figure S3A).
In particular, kinase-kinase phosphorylations are an important
element of regulatory networks and are known to modulate
signal amplification and duration (Breitkreutz et al., 2010; Gar-
rington and Johnson, 1999). Kinase-kinase regulatory interac-
tions reflected to a large extent intra- and inter-family connectiv-
ity observed in the nondirectional interaction network (Figures 3E
and S3B). For instance, members of the SRC and protein kinase
C subfamilies interacted almost exclusively with other members
of the same subfamily. The majority of inter-family regulatory cir-
cuits involved kinase-substrate interactions between CMGC and
CAMK families as well as CMGC and AGC families (Figure S3B).
In addition, CMGC kinase CDK1/CDC2 was predicted to regu-
late kinases that belonged to different kinase families but that
had similar roles in mitosis (NEK4 and PKMYT1/MYT1) or in
MAPK signaling (RAF1, IRAK1, andMAP2K2), as depicted in Fig-
ure 4F. Collectively, these analyses present the kinase interac-
tion network as a resource that, via integration of orthogonal
data, can be used to identify novel regulatory relationships with
an effect on a broad range of cellular functions.ry Interactions
e-substrate pairs, which corresponds to a significant enrichment compared to
inase-substrate interaction (depicted with red arrow). This is higher than the
stable protein complexes. Known and predicted regulatory interactions are
s between proteins from the same CORUM complex (Ruepp et al., 2010). CK2
2a2 catalytically active subunits.
. Number of predicted phosphomotifs is shown for each protein. Proteins that
s. The full set of predicted regulatory events is shown in Figure S3B. Arrows
olored according to the scheme in Figure 1.
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Next, we investigated if any of the kinase neighborhoods associ-
ated with particular genetic diseases. For this, we compared oc-
currences of specific disease terms associated with the interac-
tors of an individual kinase to the frequency of these terms in the
background human proteome (i.e., among all other proteins not
present in the kinase network). For this, we used gene-disease
annotations from the (1) Online Mendelian Inheritance in Man
(OMIM) database (Hamosh et al., 2005) and (2) DisGeNET data-
base (Piñero et al., 2015). OMIM provides curated and confident
annotations with an emphasis onMendelian diseases, while Dis-
GeNET additionally includes predicted disease associations for
both Mendelian and complex diseases. The overall number of
gene-disease associations in the latter resource is significantly
higher, but nonspecific associations can also prevent true rela-
tionships from being detected as significant. In this analysis,
we excluded cancer-associated (CA) terms, as these are a focus
of a separate analysis described below, and we excluded terms
with a very limited support in DisGeNET (see STAR Methods). In
total, 15 of the studied bait kinases had interaction neighbor-
hoods where at least one OMIM disease term was strongly over-
represented (adjusted p value < 0.05, Fisher’s exact test; Table
S7; see STAR Methods), and 137 kinases had interaction neigh-
borhoods in which at least one of the DisGeNET disease annota-
tions was strongly overrepresented (adjusted p value < 0.05,
Fisher’s exact test; Table S7; see STARMethods). The most sig-
nificant disease modules identified with either of the two re-
sources are shown in Figure 5. In nearly half of these instances,
the bait kinase was also annotated with the highlighted disease
term. The obtained kinase-disease associations cover a broad
range of medical conditions. These, among others, include
congenital disorders, psychiatric conditions, and diseases of
specific organs. Below, we describe in detail some of these
associations.
Among the most strongly enriched instances in the OMIM
analysis was a known module involved in DNA repair centered
on the CDK7 kinase (p value < 8.1 3 105). Mutation in any of
these proteins that are part of the well-studied TFIIH transcrip-
tion factor complex (Figure 2F) can lead to the development of
the skin condition xeroderma pigmentosum (Singh et al.,
2015). The same disease module was also recovered in the Dis-
GeNET analysis (p value < 1.2 3 106; Table S7) extended with
few additional proteins from the same complex (Figure 5). In
addition, the OMIM analysis highlighted a known cluster of pro-
teins around the SRPK2 kinase annotated with the disease term
retinitis pigmentosa (p value < 0.013), a serious eye disorder
leading to blindness. Further, significant DisGeNET disease
modules also included the AMPK holoenzyme, which is
composed of PRKAG2 and PRKAG3g noncatalytic subunits
and PRKAA1/AMPKa1 and PRKAA2/AMPKa2 catalytic subunits
and is known to be linked to the Wolff-Parkinson-White syn-
drome, a condition related to heart arrhythmia (p value < 3 3
106). In addition, the DisGeNET annotations suggested an as-
sociation of the module around the PAK5 kinase with schizo-
phrenia (13 out 20 interactors, p value < 104). The kinase itself
lacked this annotation (Figure 5). However, PAK5 was recently
linked to psychosis (Morris et al., 2014), and the kinase is pre-
dominantly expressed in the brain. Furthermore, both ap-proaches identified several significant disease clusters around
the POMK kinase, which we discuss in more detail below.
The analysis of OMIM Mendelian disease annotations further
reported the enrichment of the ‘‘nephronophthisis’’ term around
the NEK8 kinase. Nephronophthisis is a genetic disorder of kid-
neys that affects children. The two proteins involved in the dis-
ease development (i.e., NEK8 and ANKS6) also interacted with
the NEK7 kinase. NEK7’s physical association with this disease
module is supported by previous experimental work (Hoff et al.,
2013). In addition, we found here that two other NEK kinases
(NEK6 and NEK9), as well as the adaptor protein ANKS3, all in-
teracted with NEK7 and with each other. ANKS3 associates
with ciliary disorders (Shamseldin et al., 2016) that are etiologi-
cally related to nephronophthisis, and both ANKS3 and NEK7
were suggested to be important in development of renal ciliopa-
thies (Viau et al., 2018).
In addition to these proteins, NEK7 also interacted with pro-
teins associated with other Mendelian diseases, and some of
these interactions were not reported previously. This included in-
teractions with the TMPO protein (linked to cardiomyopathy) and
with the PGK1 kinase (with a role in hemolytic anemia and neuro-
logical dysfunction). We performed reciprocal purification of
TMPO and PGK1 proteins in a different cell line (A549) and using
antibodies against NEK7. The experiment validated these inter-
actions at NEK7 endogenous expression levels (Figure S4A).
Overall, disease modules identified here tend to associate with
pathologies of diverse organs, thus further signifying the broad
functional roles of protein kinases. Significant modules warrant
further investigations on the exact mechanisms of action and
the role of the associated kinases in the respective diseases.
POMK Frequently Associates with Membrane Proteins
Involved in Glycan Biosynthesis
Within the interaction network generated in this study, the POMK
kinase stood out as a kinase with a high number of interaction
partners (171 proteins), where themajority (i.e., 92%) of the inter-
actions were as yet not reported in PPI databases. Until recently,
POMK was considered a pseudokinase, and it had a generic
name SGK196 (Yoshida-Moriguchi et al., 2013). The kinase lo-
calizes within the endoplasmic reticulum (ER) membrane (Fig-
ure 6A) and has a role in adding a phosphate to the O-mannose
sugar moieties (Ogawa et al., 2015; Yoshida-Moriguchi et al.,
2013). One of its known substrates is dystroglycan, a receptor
that connects cytoskeleton to the extracellular matrix (Jae
et al., 2013). Using the above-described analysis of Mendelian
disease terms, we found that the interaction partners of POMK
were strongly enriched in proteins involved in muscular dystro-
phy (p value < 0.003) or in the related ‘‘congenital disorder of
glycosylation’’ (p value < 0.001). Diseases phenotypes of the
same class were also linked to the loss-of-function mutations
in POMK, which prevent phosphorylation of mannose on dystro-
glycan (von Renesse et al., 2014). Importantly, in the here-iden-
tified POMK disease module, only the interaction with the
POMGNT1 protein was previously cataloged in PPI databases
(Figure 5).
We further characterized POMK interaction partners using GO
functional and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway annotations in the DAVID database (DennisMolecular Cell 79, 504–520, August 6, 2020 513
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Figure 5. Kinase Modules Associated with Genetic Diseases
Kinase interactionmodules in which interactors with the same disease termwere present at a statistically significant frequency are shown. Shapes colored in light
green (significant baits) or gray (other bait and prey proteins) indicate that the protein lacked the respective annotation. p values indicate enrichment significance.
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OPEN ACCESS Resourceet al., 2003). This showed that POMK interaction partners were
strongly enriched inmembrane proteins, and in proteins involved
in metabolic pathways (p value < 3.63 1031 and p value < 3.53
1012, respectively; Figures 6B and 6C). This agrees with the re-
ports that many proteins associated with the same congenital
disorder phenotypes as POMK tend to function in the glycan
biosynthesis pathway and are often categorized as membrane
and metabolic proteins (Freeze et al., 2014; Yoshida-Moriguchi
et al., 2013; Zhang et al., 2018). Of note, several of the here-iden-
tified POMK interaction partners (i.e., DDOST, STT3A, STT3B,
RPN1/OST1, and RPN2 proteins) are subunits of the core N-oli-514 Molecular Cell 79, 504–520, August 6, 2020gosaccharyltransferase complex (OST), which is located in the
ER membrane. Even though O-linked glycosylation predomi-
nantly occurs in the Golgi, O-mannosylation is initiated in the
ER, and the Pmt1-Pmt2 protein complex, which mediates
mannose transfer, is in a physical proximity of the OST complex
(Bai et al., 2019). To further validate these results, we tested
POMK interactions with several of these proteins by reciprocal
co-purifications in another cell line (A549) and used POMGNT1
as a positive control. The data confirmed interactions with
STT3A, RPN1, and RPN2 proteins and thus supported POMK’s




Figure 6. POMK Kinase Frequently Interacts with Proteins Involved in Glycan Metabolism
(A) Protein sequence of the POMK kinase is depicted. The kinase is embedded in the ER membrane with the largest fraction of the protein residing within the
ER lumen.
(B) Functional GO terms and KEGG pathway annotations overrepresented in the set of POMK interaction proteins are shown.
(C) Interaction partners of the POMK kinase that according to KEGG annotations are members of metabolic pathways (53 proteins in total) are grouped based on
the KEGG pathway assignments. In the instances where the same protein belonged to several pathways, it was assigned to the larger one.
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fied using AP-MS should help in further delineating the exact
roles of this kinase in developmental and metabolic disorders
(Freeze et al., 2014).
Kinase Modules Linked to Cancer
Kinases are the most overrepresented class in the Cancer Gene
Census (CGC), i.e., a set of genes, whose mutations have been
causally implicated in cancer (Fleuren et al., 2016). Using the
generated kinase interaction network, we assessed if CA kinases
indeed interacted more often with other CA proteins. To this end,
we annotated as CA those proteins that are already classified as
cancer drivers (i.e., included in the CGC) or were reported to be
mutated at a significant frequency in cancer patients (Davoli
et al., 2013; Futreal et al., 2004; Lawrence et al., 2014; Vogelstein
et al., 2013). We found that among the interaction partners of CA
kinases, a significantly higher fraction of proteins were them-
selves annotated as CA, both when compared to the interaction
partners of non-CA kinases used as baits here or to human pro-
teins that were not in the kinase network (Figure 7A; p value <
0.005 and p value < 8 3 1015, respectively, chi-square test).
This observation hence further supports the usage of kinase
physical interactions for the study of their CA roles (Fessenden,
2017).
Next, we searched for individual kinase modules that were en-
riched in CA proteins (see STAR Methods). We identified 33 ki-
nase modules where kinase interacting proteins were signifi-
cantly enriched in CA proteins (adjusted p value < 0.05,
Fisher’s exact test; Figure S5A). In addition to kinases withwell-established cancer driver roles, such as CDK4 and CDK7,
this highlighted several other kinases linked to cellular processes
relevant for cancer development (Figures 7B, S5A, and 7C). For
instance, the PLK1 kinase, an important regulator of mitosis (Pet-
ronczki et al., 2008), which is also frequently overexpressed in
cancer (Liu et al., 2017); JNK1/MAPK8, which is known to regu-
late proliferation and apoptosis (Chen et al., 1996); and Tribbles
pseudokinase 2 (TRIB2/Trb2), which, when overexpressed, is
able to induce acute myelogenous leukemia in mice (Keeshan
et al., 2010). Of note, more than half of protein-protein interac-
tions from the subnetwork depicted in Figure 7C were newly
identified in this study. Jointly, these analyses strongly sup-
ported the notion that better mapping of CA protein modules
could add links to cancer pathways and nominate gene candi-
dates of interest while also providing a cellular context for their
activity.
DYRK2 Kinase Changes Affinity to Its Interactors during
DNA Damage Response
Kinases are known to play a central role in the regulation of DNA
damage response during cancer development (Arcas
et al.,2014). We therefore annotated proteins with a role in this
process (see STAR Methods for the definition of this list) and
looked for the modules with multiple DNA-damage-associated
proteins. Among the kinases that had five or more interaction
partners linked to DNA damage repair were SRPK kinases,
CK2 kinases, and the DYRK2 kinase (Table S8). DYRK2 is a
less well-studied kinase that can translocate to the nucleus





Figure 7. Kinase Network Associated with Cancer
(A) Interactors of CA kinases are often themselves associated with cancer.
(B) Individual kinases whose direct protein interaction neighborhoods were strongly enriched in CA proteins (p value < 0.025) are listed together with their
respective p values.
(C) Interaction network represents kinases from (B) together with their associated proteins that are annotated as CA. Coloring scheme is the same as in (B).
Significant bait kinases are highlighted with bold edges. When several of the interaction partners share the same GO term, this is indicated with the colored
background around the kinase name (most common terms are shown).
(D) Volcano plot indicates the enrichment of Dyrk2 interaction partners identified by BioID-MS compared to the GFP control (BirA-taggedGFP). Proteins enriched
with a log2FC (Dyrk2/GFP)R 1 (adjusted p value% 0.05) were considered as high-confidence interactors (thresholds are indicated with dashed lines). Interactors
identified by both BioID-MS and AP-MS measurements are presented as green dots (11 were detected with a high confidence).
(E) Quantitative changes in the Dyrk2 interactions after the treatment with Adriamycin (ADR) are shown. Only interaction partners identified with both AP-MS and
BioID are shown. Significant changes (log2FC (ADR/ctr) R 1 and adjusted p value % 0.05) are indicated with an asterisk.
ll
OPEN ACCESS Resource2007). The kinase is known to form a stable E3 ligase complex
with DDB1 (DNA-damage-binding protein 1), UBR5, and VPRBP,
and it was hypothesized that DYRK2’s role in the DNA damage
response is likely to depend on its stable interaction with
DDB1 (Bensimon et al., 2011). Here, with AP-MS, we additionally
identified a new interaction between DYRK2 and BIRC6, a scaf-
fold protein that assists recruitment of DNA damage factors to
DNA breaks (Ge et al., 2015a, 2015b). To validate the AP-MS in-
teractions and additionally assess if DYRK2 interactors change
during the DNA damage response, we performed BioID-MS ex-
periments in HEK293 cells under normal conditions and upon the
treatment with the genotoxic agent Adriamycin (ADR). The Bio-
ID-MS analysis confirmed 11 DYRK2 interactions initially identi-
fied by AP-MS (Figure 7D). Among these were the above
mentioned BIRC6 and proteins from the stable E3 ligase com-
plex (DDB1, UBR5, and VPRBP). However, after ADR treatment,
DYRK2 interactions with both BIRC6 protein and the associated
E3 ligase complex were reduced (Figure 7E), thus suggesting
that DYRK2 is likely to act independently during DNA repair. In
contrast, ADR treatment increased interactions between
DYRK2 and several proteins that can promote phase transition,
such as SRRM2 (Rai et al., 2018). In addition to interaction part-
ners that overlapped with AP-MS, BioID-MS showed that ADR
treatment induced stronger binding of DYRK2 to P53, GTSE1,516 Molecular Cell 79, 504–520, August 6, 2020and several other DNA-damage-associated proteins (Figures
S5B–S5D). Overall, the observed quantitative changes among
DYRK2 interaction partners suggest that DYRK2 could have a
role in the DNA damage response that is independent of the
DDB1 protein and the core E3 ligase complex.
DISCUSSION
Here, we present the first comprehensive interaction map for the
human kinome. Understanding the biochemical context of pro-
tein kinase activity is crucial to decode the architecture of cellular
signaling and ultimately interpret disease-associated genomic
variation. Notwithstanding the high level of comprehensiveness
of the interactome mapping performed here, the study has
several known limitations that are inherent to large-scale AP-
MS experiments. The results did not capture many physiologi-
cally relevant interactions, such as for instance cell-line-specific
interactions or interactions that occur only upon specific stimuli.
Similarly, mutated kinases may have distinct interactomes and
some of the interactions crucial for disease development will
not be observed with wild-type isoforms used here. In addition,
AP-MS is likely to miss many transient but physiologically rele-
vant interactions, and the protocol we used here is not tailored
towards large-scale identification of interactions that occur
ll
OPEN ACCESSResourceamong membrane or nuclear proteins. Furthermore, overex-
pressed or misfolded kinases will have a stronger interaction
with Hsp90 and other chaperones, and some of the interactions
could occur only after cell lysis. It is also important to note that 20
of the studied kinases are not endogenously expressed in the
HEK293 cell line used here and 37 other kinases are expressed
only at very low levels (Table S9). Finally, the kinase constructs
used in the study may not reflect the exact isoforms expressed
in human cells (Table S9), and the performed N-terminal tagging
of the constructs could have affected protein stability, localiza-
tion, and binding. These caveats are important to bear in mind
when assigning new roles to kinases based on their interaction
neighborhoods.
Kinases tend to have a relatively high number of interaction
partners and pleiotropic roles in the cell (Huttlin et al., 2017; La-
hiry et al., 2010), so it is not uncommon that the same kinase fam-
ily associates with different disease phenotypes (Lahiry et al.,
2010). For instance, DYRK2 is also involved in the regulation of
proteasome-mediated protein degradation and cell proliferation
through phosphorylation of the Rpt3 19S proteasome subunit
(Guo et al., 2016). Here, we predict a number of novel modules
where interaction partners of the studied kinases share the
same disease associations (Figure 5). Better mapping of such
modules can aid understanding of kinase roles in the cell and
in disease development (Cheng et al., 2014; Csermely et al.,
2013; Goh and Choi, 2012), as we suggest here for NEK7,
PAK5, and other kinases. Furthermore, mutations that drive can-
cer development often affect kinase regulation and their interac-
tion properties (Buljan et al., 2018). Combined with the rich can-
cer genomics data, context information from the kinase
interaction network can be of a high value for identifying ki-
nase-linked cancer drivers and establishing a link to cancer pa-
thologies, which is not readily evident from mutation patterns
alone. Importantly, there are currently more than 50 approved ki-
nase inhibitors and more than 130 in clinical trials (Wilson et al.,
2018). This emphasizes the direct relevance of the mapped dis-
ease and functional modules. Moreover, these interactions shed
a new light on the biology of several under-investigated kinases,
such as POMK and PIM3. Furthermore, the generated interac-
tion network is able to assist kinase-substrate predictions, as
illustrated here by epigenetic complexes that we predict to be
controlled by CK2 holoenzyme (Figure 4D).
Overall, well-defined interaction modules can be a valuable
resource for integrating incomplete functional and disease data
on human genes. In this regard, the kinase interaction network
represents a stepping stone toward a systemic understanding
of kinases biochemical context, function, and regulation.STAR+METHODS
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Silencer select WNK3 siRNA ThermoFisher s35279
Silencer select POMK siRNA ThermoFisher s534531
Silencer select POMK siRNA ThermoFisher s534532
Silencer select NEK7 siRNA ThermoFisher s44315
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Expression constructs
To generate expression vectors for doxycycline-inducible expression of N-terminal Strep-HA-tagged bait proteins, humanORFs pro-
vided as pDONR223 vectors were selected either fromaGateway compatible human orfeome collections horfeome v5.1, horfeome
v8.1 and ORFeome Collaboration Clones (OpenBiosystems, Horizon Discovery) or from the collection of kinome constructs (Varjo-
salo et al., 2008) for LR recombination with the destination vector pcDNA5/FRT/TO/SH/GW (Glatter et al., 2009). Information on this is
provided in the Table S9.
Stable cell line generation
HEK Flp-In 293 T-Rex cells (Invitrogen) containing a single genomic FRT site and stably expressing the tet repressor were cultured in
DMEM medium (4.5 g/l glucose, 2 mM L-glutamine, Invitrogen) supplemented with 10% FCS, 50 mg/ml penicillin, 50 mg/ml strepto-
mycin, 100 mg/ml zeocin and 15 mg/ml blasticidin. The medium was exchanged with DMEM medium (10% FCS, 50 mg/ml penicillin,
50 mg/ml streptomycin) before transfection. For cell line generation, Flp-In HEK293 cells were co-transfected with the corresponding
expression plasmids and the pOG44 vector (Invitrogen) for co-expression of the Flp-recombinase using the Fugene6 transfection
reagent (Roche). Two days after transfection, cells were selected in hygromycin-containing medium (100 mg/ml) for 2–3 weeks. Of
note, HEK293 used here are transformed by adenovirus and they express adenoviral oncoproteins E1A/B.
METHOD DETAILS
Protein purification
Following hygromycin selection, stable isogenic HEK293 cell pools were grown in eight 14 cm Nunclon dishes to 80% confluency,
1.3 mg/ml doxycycline (Sigma) was added for 24h to induce the expression of SH-tagged bait proteins and harvested with PBS con-
taining 10 mM EDTA. Cells were collected, frozen in liquid nitrogen and stored at 80C prior to protein complex purification. Effec-
tively, > 1x108 cells were used per pulldown.
The frozen cell pellets were resuspended in 4 mL HNN lysis buffer (50 mMHEPES pH 7.5, 150 mMNaCl, 50 mM NaF, 0.5% Igepal
CA-630 (Nonidet P-40 Substitute), 200 mM Na3VO4, 1 mM PMSF, 20 mg/ml Avidin and 1x Protease Inhibitor mix (Sigma) and incu-
bated on ice for 10 min. Insoluble material was removed by centrifugation. Cleared lysates were incubated on a rotating wheel at
4C with 50 ml pre-equilibrated Strep-Tactin Sepharose beads (IBA Biotagnology) for 15min and loaded on a spin column (Bio-
Rad). The beads were washed two times with 1 mL HNN lysis buffer and three times with HNN buffer (50 mM HEPES pH 7.5,
150 mM NaCl, 50 mM NaF). Bound proteins were eluted with 600 ul 0.5 mM Biotin in the HNN buffer. To remove the biotin, eluted
samples were incubated for 1 h in presence of 25% TCA on ice, washed with acetone, air-dried and re-solubilized in 50 ml 8 mMUrea
in 50mMNH4HCO3 pH 8.8. Cysteine bonds were reducedwith 5mMTCEP for 30min at 37
C and alkylated in 10mM iodoacetamide
for 30 min at room temperature in the dark. Samples were diluted with NH4HCO3 to 1.5 M Urea and digested with 1 mg trypsin (Prom-
ega) overnight at 37C. The peptides were purified using C18 microspin columns (The Nest Group Inc.) according to the protocol of
the manufacturer and eluted with 0.1% formic acid, 3% acetonitrile for mass spectrometry analysis.
Affinity purification and western blotting
For Co-AP and western blotting analysis shown in Figure S4B 5x 105 A549 cells were co-transfected with plasmids for the transient
expression of the V5-tagged kinase and SH-tagged proteins using jetPRIME transfection Reagent (114-15, Chemie Brunschwig AG).
The transfected cells were lysed 24 hr after transfection in 1mL of HNN lysis buffer (50mMHEPES pH 7.5, 150mMNaCl, 50mMNaF,
0.5% Igepal CA-630 (NP-40 substitute), 200 uMNa3VO4, 1mMPMSF, and 1x Protease Inhibitor mix (sigma)). The cleared lysate was
incubatedwith 15 mL equilibrated Streptactin beads (Streptactin superflow 50%, IBA) o/n at 4Con a rotation shaker. The beadswere
washed three times with the lysis buffer and after final wash the complexes were eluted in 50 mL of 3X Laemmli buffer. The samples
were boiled for 5 min, separated by PAGE and transferred to nitrocellulose membranes (Whatman GmbH, Germany). Immunopre-
cipitated proteins were detected either with anti-HA (HA-11, 901513, Lucerna Chemie AG)) or anti-V5 (R960-25, Life technologie Eu-
rope BV) primary and secondary horseradish peroxidase (HRP)-conjugated secondary antibodies (anti-mouse, labforce) by
enhanced chemiluminescence. For the detection of complexes with endogenous NEK7 kinase (Figure S4A), A549 cells were trans-
fected with vectors expressing SH-tagged proteins, lysed, lysates purified and subjected to western blotting as described above.
Endogenous NEK7 protein was detected by western blotting of the Streptactin purified samples using primary anti NEK7 antibodies
(Abcam, ab133514) and secondary anti-rabbit IgG HRP-conjugated antibody (Cell Signaling, #7074S).
Mass spectrometry
LC-MS/MS analysis was performed on a Thermo Orbitrap Elite mass spectrometer (Thermo Fisher Scientific). Peptide separation
was carried out by a Thermo Easy-nLC 1000 HPLC system using a 15 cm long, 75 mmdiameter ID PepMap column (Thermo, particleMolecular Cell 79, 504–520.e1–e9, August 6, 2020 e3
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in water; B: 3%water, 0.1% formic acid in acetonitrile. The data acquisitionmodewas set to obtain one high resolutionMS scan in the
Orbitrap (240,000@400 m/z). The 10 most abundant ions from the first MS scan were fragmented by collision induced fragmentation
(CID) and MS/MS fragment ion spectra were acquired in the linear ion trap at normal scan rate. Charge state screening was enabled
and unassigned or singly charged ions were rejected. Precursor isolation width was 2 m/z in all cases and dynamic exclusion was
enabled for 30 s. After every technical replicate set, a peptide reference sample containing 200 fmol of human [Glu1]-Fibrinopeptide
B (Glufib) (Sigma-Aldrich) was analyzed to monitor the LC-MS/MS systems performance.
Carry-over was systematically controlled through all theMS runs. Each subsequent control (Glufib)measurement and bait replicate
set were manually screened for the presence of previous bait and most abundant interaction candidate peptides. Samples with car-
ried-over interacting proteins were re-measured using cleaned LC columns.
Kinase classification
To classify kinases in families, we used as primary reference the Uniprot annotation (reported either in individual entries or in the sum-
mary file https://www.uniprot.org:443/docs/pkinfam.txt, released July 2016). For kinases that were not classified in Uniprot and for
Atypical kinases, we used the classification from (Manning et al., 2002) (http://kinase.com/web/current/kinbase/). For three kinases
for which the classification was ‘‘other’’ in Uniprot, we followed the more specific classification by Manning and colleagues (Q96S38
and Q9Y6S9 classified as AGC; P49842 classified as Atypical). The following proteins were not considered in the classification but
were kept in the interactome: 1) two putative kinases: Q9UJY1 and Q12792. 2) Non-catalytic subunits of the 50-AMP-activated pro-
tein kinase: Q9UGI9, Q9UGJ0, O43741, P54619. Similarly, subfamily classification was primarily based on Uniprot and integrated
with information reported in Manning et al., 2002. TheManning classification contains up to three classes (Group, Family, Subfamily);
for consistency, we refer to the highest Manning class as ‘‘Family’’ and the first subordinate class as ‘‘Subfamily,’’ even if the first
class is in some instances, e.g., AGC, defined as Group. The classification is reported in Table S1.
Citation analysis
Citation data for kinome baits were downloaded (July 2017) from ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/gene2pubmed.gz using their
geneIDs. Pubmed ID counts for entries with multiple geneIDs were summed up (kinase P57078 was not considered for analysis, as it
doesn’t have an associated geneID). The number of unique publicly available interactions was derived from the Integrated Interaction
Database (IID; version 2017-04). The full data is reported in Table S1. Red line in Figure 2A that represents a running average of the
citation number was calculated using R package zoo (k = 5).
Reference databases and comparison with HT AP-MS studies
We used as a reference database for published and deposited interactions the integrated interaction database (IID) (Kotlyar et al., 2016)
(version2017-04, unless statedotherwise). BioGridwasused for the calculation of the fraction of the identified interactions that havebeen
already deposited. For protein complexes, we used the list of core CORUM complexes (release: 02.02.2017; http://mips.helmholtz-
muenchen.de/corum/#download) and removed residual duplicates complexes as well as complexes with only a single protein. Baits
from (Hein et al., 2015) were identified from column ‘expected.bait.reference.uniprot.id’ column in the ‘bait cell line’ sheet, supplemental
data. BaitsGeneIDs fromHuttlin et al. (2015) andHuttlin et al. (2017)weremapped toUniprotIDs usingUniprot Retrieve/IDMapping func-
tion (Uniprot,December2018) and reviewedentrieswereused for thecomparison (17 and30unmappedGeneID identifiers, respectively).
GO analysis
As input for the GO analysis, we used the combined (non-redundant) interactome from the kinome/IID (version 2018-05) for all sub-
groups with at least 3 proteins among our baits, including the baits and excluding chaperones. The analysis was carried out using the
R package RDAVIDWebService (Fresno and Fernández, 2013), using as annotation category ‘‘GOTERM_BP_DIRECT’’ and selecting
all the entries with an adjusted (Benjamini-Hochberg) p value < 0.05, or up to the top 5 entries in the instances when less than 5 entries
satisfied the significance threshold. Specific GO terms were manually collapsed into more general ones; first, by clustering terms
together based on semantic similarity and then by choosing shared terms among the inferred trees (AmiGO 2 version 2.5.12) of those
GO terms. When multiple terms for the same subfamily were mapped to the same general term, the lower p value value has been
represented in Figure 3A. To measure semantic similarity between Kinome network and IID interaction networks, we compared
GO terms associated with the Kinome and IID for the indicated subgroups (as defined above). The comparison was carried out
with R packages GOSemSim (v. 2.6.2)(Yu et al., 2010), using the Wang similarity measure.
To classify interactors among phosphatases, ubiquitin ligases, DUB enzymes, transcription factors and epigenetic factors, and to
define protein complexes belonging to the latter class, we relied on curated information included in, or associated with, the following
publications (Li et al., 2008; Medvedeva et al., 2015; Nijman et al., 2005; Sacco et al., 2012; Wingender et al., 2013). To evaluate the
fraction of novel interactions including interactors belonging to these classes, we used as a reference the IID (Kotlyar et al., 2016)
(version 2017-04).
Network visualization
Protein Interaction data was visualized with Cytoscape 3.6.0 (https://www.cytoscape.org/) (Kohl et al., 2011).e4 Molecular Cell 79, 504–520.e1–e9, August 6, 2020
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In order to assess the overrepresentation of functional domains, domain assignments were downloaded from the Pfam database
(Pfam 31.0, March 2017) (Finn et al., 2016). Proteins identified as interaction partners of protein kinases were compared to all other
proteins in the reference human proteome (Uniprot-all table from the Uniprot database obtained in June 2018, containing 20,361 en-
tries in total) (UniProt Consortium, 2015). Only proteins with at least one annotated domain were considered. For each domain, a
fraction of proteins with the domain was compared between the kinase interactors and background proteins. Significantly overrep-
resented domains were identified with one-sided Fisher’s exact test in R and the obtained p values were corrected using the Benja-
mini-Hochberg method.
Prediction of kinase-substrate interactions
In order to predict the phosphosites and the possible upstream kinases, NetPhorest software tool (distribution November 2013)
(Miller et al., 2008) was locally installed and ran on the fasta sequences of all proteins in the kinase interaction network. The output
of this analysis is a position of each Serine, Threonine or Tyrosine that is found within a motif which could be recognized by one or
more kinase groups and a posterior probability for each group. As the predicted phosphosites we kept only residues that were exper-
imentally found to be phosphorylated: either by a small-scale study or by five or more large-scale studies deposited in the Phospho-
sitePlus database (release November 2018). For each individual site, we considered only the top three predicted kinase groups and
required a minimum posterior probability of 0.035, as well as the posterior to be higher than the prior (Freschi et al., 2014; So et al.,
2015; Tan et al., 2009). Individual kinase groupmembers were assigned to each upstream kinase group based on the file provided by
the NetPhorest support team and based on the kinase family or subfamily namematch to the NetPhorest groups. Finally, the kinase-
substrate relationships predicted from the sequence features were considered further only when they were additionally supported by
the physical interaction in the filtered AP-MS interaction data obtained here.
A list of the known kinase-substrate pairs was obtained from the PhosphoSitePlus database (data extracted in Nov 2018), (Horn-
beck et al., 2015). This dataset was overlapped with the Kinase interaction network and the number of interactions that agreed with
the annotated regulatory events was noted. In order to assess if this was higher than expected, random networks were composed.
These preserved the size and topology of the kinase network, i.e., the distribution of the number of interactors per individual kinase,
and interactors were randomly sampled from the pool of all prey proteins identified in the study. This was repeated 1,000 times and
each time the total number of interaction partners that were also known kinase-substrate pairs was noted. Distribution of the values
observed for the random networks was compared to the corresponding value for the original Kinase network using the pnorm test in
R. Reciprocal regulation, i.e., instances where two kinases interacted and both were known to phosphorylate each other, were
counted as a single interaction event. Next, we evaluated the observed number of predicted kinase-substrate regulatory events.
Analogous to the approach used for known substrates, random networks were generated in the same way and the number of pre-
dicted kinase-substrate events in the kinase network was compared to the distribution of these values for random networks with the
pnorm test in R. The subnetwork with kinase-kinase regulatory interactions was obtained by asking that both the kinase and the sub-
strate are listed as kinases according to Manning annotations included in Table S1 (Manning et al., 2002). Additionally, the number of
predicted phosphosites in each substrate protein was counted and proteins withmore than five phosphosites that are predicted to be
regulated by the same kinase were noted. Kinases that had more than five substrate proteins with multiple, i.e., six or more, phos-
phosites, were then investigated in more detail.
Many kinases that belong to the AGC, CAMK, CMGC or Tyrosine Kinase families have conserved sequence segments around the
more variable active loop region (located between the Mg binding and P+1 loops). Phosphosites that map within the active loop are
often associated with specific roles and they can function as regulatory switches for kinase activity. In order to identify active loop
coordinates in the predicted substrate kinases, all bait kinases were aligned using the multiple sequence alignment tool Clustal
Omega (Sievers et al., 2011). For this, we noted positions of activation loops in exemplary well-annotated kinases and used the
sequence alignment to infer positions of these in other kinases. Based on differences in sequence motifs we used as reference ki-
nases CDK9 from CMGC family and BRAF from TLK family. Amino acid (aa) positions before and after the activation loop were noted
in both CDK9 and BRAF kinase. For all other bait kinases it was assessed if the regions before and after the less-conserved activation
loops in CDK9 (first choice) or BRAF shared a sequence similarity with the aligned regions in these proteins (for instance, kinases from
CMGC family had an excellent alignment with CDK9 annotated regions). To consider that there was a sequence conservation in the
regions surrounding the active loop, the predicted active loop sequence segment had to be between 5 and 50 amino acids long and
at least half of the amino acids in sequence segments around the active loop had to be similar and aligned. The length of the sur-
rounding regions was estimated from sequence annotations and alignment with other kinases and it was 9 and 7 amino acids for
CDK9 and 11 and 9 amino acids for BRAF for the segment preceding and after the activation loop, respectively. Finally, when appli-
cable, phosphosites in the predicted substrate proteins were mapped to the active loop coordinates defined in this way. This high-
lighted 25 predicted substrate kinases in which one or more regulated phosphosite was within an active loop (this information is
included in the Table S6).
In addition to phosphosites, sequences of predicted substrates were searched for the presence of docking motifs that could be
recognized by protein kinase domains. For this, annotations in the annotated eukaryotic linear motifs were downloaded from the ELM
database (ELM 2016) (Dinkel et al., 2016).Molecular Cell 79, 504–520.e1–e9, August 6, 2020 e5
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To obtain confident annotations for human gene-disease relationships, ‘‘morbidmap’’ table with the curated data on known Mende-
lian disorders was retrieved from the Online Mendelian Inheritance in Man (OMIM) catalog (a dataset generated in January 2017) (Ha-
mosh et al., 2005). OMIM associates diseases to gene names, so all gene names assigned to individual Uniprot identifiers were
searched. Because similar disease phenotypes can have slightly different OMIM terms, each disease term was comma separated,
unspecific character symbols were removed, and only the expression before the first commawas assigned to the associated protein.
Additionally, as a control, all proteins in the kinase network were annotated with individual words occurring in OMIM terms. Six ex-
pressions that were not capturedwith the above approach, but were re-occurring in the kinase network, were separately evaluated as
regular expression terms (these terms were: ‘‘glycogen storage disease,’’ ‘‘mental retardation,’’ ‘‘thalassemia,’’ ‘‘deafness’’ and
‘‘ventricular’’). Cancer-associated terms were skipped as these were analyzed separately. Only terms that were shared among three
or more proteins in the kinase network were considered in the further analyses. Finally, to reduce the unspecific enrichments, actin
and myosin proteins as well as chaperone proteins (defined as having HSP or chaperone in the gene name, or HSP, CPN60 or FKBP
domain in the protein sequence) were excluded from the analysis. To identify disease modules, frequency of these terms in each
individual kinase neighborhood - composed of the kinase itself and its direct interactors – was compared to the frequency of the
terms in the background set. Background set was composed of Uniprot proteins in the representative human proteome (version
August 2016 with 20,197 entries in total) after excluding proteins identified in the kinase network. In addition, only proteins with at
least one OMIM annotation were included in the analysis. To identify disease terms overrepresented around individual kinases,
Fisher’s exact test followed with Benjamini-Hochberg correction was applied. Significant terms were visualized and at this step three
mitochondrial ribosomal proteins around the MAST1 kinase were removed. The kinase is located within cytoplasm and has a role in
cytoskeleton regulation, so there is a risk that these could be false identifications.
Functions associated with the POMK interaction partners were investigated separately. Information on the GO terms and KEGG
pathways that weremost strongly overrepresented in a comparison with all other human proteins was obtained using the annotations
in DAVID database (release 6.8). Terms that were highly significant (p value < 0.0001, Benjamini Hochberg correction) and where
gene sets annotated with the particular term were not subsets of the more significant terms were visualized (i.e., overlapping terms
are not reported in the figure).
In order to expand the list of gene-disease associations, DisGeNET v5.0 table with all available associations was retrieved (Piñero
et al., 2015). This included annotations with different confidence levels and gene-disease relationships that were of a lower confi-
dence were skipped. These were the terms supported only (i) either by the BeFree text mining system, or (ii) Human Phenotype
Ontology, or (iii) Genetic Association Database or (iv) only by Comparative Toxicogenomics Database. Analogously to the OMIM
analysis, only disease terms annotated to at least three proteins from the kinase network were considered, and kinase interaction
partners that were chaperones, actin or myosin proteins, were omitted from the analysis. Additionally, all cancer-associated terms
were skipped as cancer was studied separately. Again, occurence of each term was counted within each kinase neighborhood, and
significant overrepresentation compared to the background human proteins (i.e., UniProt reference proteome after excluding pro-
teins identified in this study) was assessed with the Fisher’s exact test, followed with the Benjamini Hochberg correction. For the
consistency in calculations, chaperones, actins and myosin proteins were also excluded from the background set and only proteins
with at least one DisGeNET annotation were considered.
Cellular phenotype assay
In order to identify kinases whose interaction partners are enriched in roles associated with cell shape regulation we searched for the
interactors annotated with Uniprot GO terms that contained the words ‘ciliary’, ‘cytoskeleton’, ‘polarity’, ‘kinasin’, ‘microtubule’,
‘focal adhesion’, ‘cell adhesion’, ‘lamellipodium’, ‘mitotic’ or ‘actin filament’. To increase the specificity of the identified kinases,
enrichment was calculated by excluding (i) chaperones (i.e., interactors with HSP, Cpn60 or FKBP domain, or those that contained
HSP or chaperon in their name), (ii) cytoskeletal proteins that frequently copurify in AP-MSwith different baits (this was donewith text-
mining of protein names, and those that contained MYH, ACTIN, or started with CCT, ACT, ACL or ARP were skipped), and (iii) pro-
teins that interacted with more than 10 different kinases. Enrichment was calculated by comparing interactors of individual kinases to
the background of all Uniprot proteins. Significant kinases that already had strong support and a confident GO term that indicated
their role in the cellular shape regulation were excluded. In addition to kinases selected in this way, we included in the screen kinases
from the NEK7 interaction neighborhood (NEK6 and NEK9) and, based on preliminary literature links, also the SCYL3 pseudokinase.
Finally, positive and negative control siRNAs were also included in the screen. Whenever possible, validated ThermoFisher siRNA
reagents were used in the experiments.
Two human cell lines LN-229 (glioblastoma cell line) and SKOV3 (ovarian cancer cell line) were used for the siRNA silencing exper-
iments. LN-229 cells were cultured in DMEM media supplemented with 2% FBS, 1% Pen-strep, and 25mM HEPES while SKOV3
cells were cultured in RPMI-1640 media supplemented with 10% FBS and 1% Antibiotic-Antimycotic (all products from GIBCO).
Cells were passaged at approximately 70% confluency with 0.25% Trypsin-EDTA (GIBCO, 25200056) and seeded at 0.7-1.0x103
cells/well into clear-bottom, tissue-culture treated, CellCarrier-384 Ultra Microplates (Perkin Elmer, 6057300) with three replicate
wells per condition. Silencer Select Pre-Designed siRNAs (Table S5) were transfected at 0.66 pmol/well using Lipofectamine RNAi-
MAX (Invitrogen, 13778075). Both the siRNAs and Lipofectamine transfection reagent were dispensed using a Labcyte Echo liquid
handler in a randomized plate layout to control for plate effects. For each gene target, between 1-3 siRNAs were tested for both celle6 Molecular Cell 79, 504–520.e1–e9, August 6, 2020
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PBS, blocked for 1 hour at room temperature in blocking solution (PBS containing 5%FBS and 0.1%Triton). Cells were stained over-
night at 4C in blocking solution with the following antibodies: Alexa Fluor 488 anti-Vimentin (1:1000, Biolegend, #677809), Alexa
Fluor 647 anti-Tubulin Beta 3 (1:1000, Biolegend, #657406) and DAPI (10mg/ml, 1:1000, Sigma Aldrich). High-content imaging
was performed with an Opera Phenix automated spinning-disk confocal microscope at 20x magnification (Perkin Elmer,
HH14000000). Tomeasure cell area shape features, single-cells were segmented using CellProfiler 2.2.0 (McQuin et al., 2018). Nuclei
segmentation relied on the DAPI channel, while LN-229 cytoplasmic segmentation utilized the Tubulin Beta 3 (TUBB3) channel and
the SKOV3 cytoplasmic segmentation utilized the Vimentin (VIM) channel. CellProfiler module ‘MeasureObjectSizeShape’ based on
the cytoplasmic segmentation was used to derive 18 different cell area shape features. Area shape features that were not dependent
on cell density were chosen for plotting. Downstream image analysis and data visualization was performed with MATLAB R2019a
where single cell feature data was averaged across each well/condition and compared to the negative siRNA control. Student’s
paired t test was performed to calculate statistical significance.
Identification of kinase modules associated to cancer
Kinase modules with overrepresentation of CA proteins were identified in a similar approach as other disease modules. The list of
known CA proteins was compiled from the known cancer drivers deposited in the Cancer Gene Census (version January 2017) (Fu-
treal et al., 2004) and from a prominent review on the roles of cancer proteins (Vogelstein et al., 2013). Additionally, the list of CA pro-
teins was extendedwith those identified as frequently mutated in two recent comprehensive analyses of pan-cancer patient mutation
data (Davoli et al., 2013; Lawrence et al., 2014). In this and the following analyses, heat shock proteins were excluded due to their
broad scope of kinase interaction partners. In order to assess if the interactome of CA kinases was enriched in other CA proteins,
a set of all kinase interaction partners was divided into those that interacted with one or more of the CA kinase baits and all other
interactors, and a fraction of CA proteins was noted in each set. Additionally, a background fraction of CA proteins was calculated
in the set of all other Uniprot proteins in the representative human proteome after excluding proteins in the kinase network (UniProt
Consortium, 2015) (version August 2016). A tendency of CA kinases to interact with proteins that are also associated with cancer was
assessed with the chi-square test in the comparison to two other sets.
Next, a fraction of CA proteins in each kinase neighborhood, i.e., a set of proteins formed by each kinase and its interactors, was
calculated and compared to the fraction of CA proteins in the background set of all other Uniprot proteins, when excluding those in
the kinase network. Modules with at least two CA proteins were assessed and significant clusters were identified using the Fisher’s
test and Benjamini Hochberg correction for the obtained p values. DYRK1A/B kinases were excluded from the final list of significant
kinase clusters due to their known interaction with adenoviral E1A protein expressed in HEK cell line (Komorek et al., 2010). Further-
more, the interaction network for the most significant modules (adjusted p value < 0.025) was visualized using the Cytoscape soft-
ware (Kohl et al., 2011). In order to functionally annotate the significant modules, KEGG, Biocarta and GO biological process anno-
tations were retrieved for all proteins in the network using DAVID service (Dennis et al., 2003). Terms that were most frequently
occurring within each module were listed, and manually checked in order to select the ones that are most frequent, and when
possible, that occur also in other modules in the network.
BioID experiments
The expression of FLAG-BirA*-tagged Dyrk2 (T-REx-HEK293 Flp-In cells) or Pim3 (T-REx-HeLa CCL2 Flp-In cells) was induced by
addition of 4ug/ml doxycycline for 24h in one 150 mm tissue culture plate. Then the media was replaced by fresh media supple-
mented with 50 mm biotin and cells were incubated for additional 24h. Cells were harvested and snap frozen in liquid nitrogen fol-
lowed by cell lysis in 1mLRIPA buffer (50mMTris-HCl (pH 8), 150mMNaCL, 1%Triton X-100, 1mMEDTA, 0.1%SDS supplemented
with 1mMPMSF and protease inhibitor cocktail (Sigma)) and Benzonase (Sigma) treatment (250U) at 10C for 30min. Cell debris was
removed by centrifugation (20000 x g, 20 min at 4C) and the cleared cell lysate was incubated with disuccinimidyl suberate (DSS)
(Sigma) crosslinked Strep-Tactin beads (IBA LifeSciences) for 1h on a rotation shaker at 4C. Then beads were washed three times
with RIPA buffer, three times with HNN buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 50 mM NaF) and two times with 100 mM
NH4CO3. For protein denaturation the beads were incubated with 8 M urea followed by reduction with 5 mM Tris(2-carboxyethyl)
phosphine TCEP and protein alkylation with 10 mM iodoacetamide. The sample was diluted to 4 M urea with 100 mM NH4CO3
and proteins were digested on the beads with 0.5 mg LysC (Wako) for 3h followed by dilution to 1 M urea and digestion by 0.8 mg
trypsin overnight. In order to stop protein digestion 5% formic acid was added and the peptides were purified by
C18 UltraMicroSpin columns (The NestGroup) and dried in a speedvac. The dried peptides were dissolved in 2% acetonitrile and
0.1% formic acid.
BioID-MS data analysis
In general, BioID-MS experiments were performed in triplicates (n = 3). Acquired MS/MS scans were searched against the
UniProtKB/Swiss-Prot protein database (31.03.2016) using MaxQuant v1.5.2.8 (Cox and Mann, 2008) with default parameters.
High confidence interactors of FLAG-BirA*-Dyrk2 were determined by filtering against proteins identified in FLAG-BirA*-GFP control
experiments. Proteins significantly enriched (log2FC R 1, adj. p value % 0.05) compared to the GFP control were considered as
high confident interaction partners. The fold change of interactors was calculated based on precursor MS1 values (LFQ intensities)Molecular Cell 79, 504–520.e1–e9, August 6, 2020 e7
ll
OPEN ACCESS Resourcedetermined byMaxQuant v1.4.2.8. The statistical analysis was performed by customized R scripts. Briefly, MS1 intensities were me-
dian-normalized and missing values were imputed using random sampling from a distribution based on the 5th lowest quantile.
Changes in the Dyrk2 BioID interaction network upon perturbation were quantified using bait-normalized precursor MS1 intensities
(LFQ intensity). The statistical analysis was performed as described above.
For the identification of high confident interaction partners of FLAG-BirA*-Pim3 expressed in HeLa CCL2 cells the BioID-MS inter-
action dataset was filtered with SAINTexpress (Mellacheruvu et al., 2013) using default parameters and sixteen control experiments
(FLAG-BirA* and FLAG-BirA*-GFP expressed in HeLa CCL2 cells) of the CRAPome database (http://crapome.org/). IDs assigned
with a SAINT score = 1 were considered as high confidence interactors.
DNA damage induction
To generate a reference list of DNA repair proteins, we obtained a set of proteins which are confidently annotated with the process
(Arcas et al.,2014) and we extended it with proteins that were shown to physically migrate to the foci of DNA damage after UV laser
microirradiation (Izhar et al., 2015). In order to confirm BIRC6 as new Dyrk2 interaction partner and to investigate Dyrk2 interactome
remodeling in response to DNA damage we performed BioID-MS interaction analysis with BirA-tagged Dyrk2 under normal condi-
tions and upon induction of DNA damage by Adriamycin (ADR). In contrast to AP-MS, proximity labeling by BioID allows stringent
lysis conditions that disrupt the nuclear membrane and facilitates the identification of nuclear interaction partners. To induce geno-
toxic stress HEK293 cells were treated with 2 mg/ml ADR for 24h and the quantification of changes in the Dyrk2 interactome was
based on precursor MS1 intensities obtained from MaxQuant v1.5.2.8. Interaction partners were accurately quantified with a repli-
cate CV < 9% and the triplicates of untreated and ADR treated cells emerge as individual cluster (Figure S5B).
QUANTIFICATION AND STATISTICAL ANALYSIS
Protein identification
Acquired spectra were searched with X!Tandem (Craig and Beavis, 2004) (release 2011.12.01) against the canonical human proteome
reference dataset (http://www.uniprot.org/), extended with reverse decoy sequences for all entries. The search parameters were set to
include semi-tryptic peptides (KR/P) containing up to two missed cleavages. Carbamidomethyl (+57.021465 amu) on Cys was set as
static peptidemodification. Oxidation (+ 15.99492 amu) onMet and phosphorylation (+79.966331 amu) on Ser, Thr, Tyr were set as dy-
namic peptide modifications. The precursor mass tolerance was set to 25 ppm, the fragment mass error tolerance to 0.5 Da. Obtained
peptide spectrummatches were statistically evaluated using PeptideProphet and protein inference by ProteinProphet, both part of the
TransProteomicPipeline (TPP, v.4.6.0) (Deutschetal., 2010).Aminimumprotein probability of 0.9wasset tomatcha falsediscovery rate
(FDR) of < 1%. The resulting pep.xml and prot.xml files were used as input for the spectral counting software tool Abacus to calculate
spectral counts and values (Fermin et al., 2011) (release 2013.02.14). Raw MS data is available at the following site: https://db.
systemsbiology.net/sbeams/cgi/PeptideAtlas/PASS_View?identifier=PASS01469. The site also includes peptide identifications from
all MS runs (all_pep_xml_together.txt), and provides the script and instructions for filtering that corresponds to Abacus criteria and gen-
erates peptide identifications used in this study (processingPepXml.pl and NOTES_ON_PEP_XML).
Evaluation of high confidence interacting proteins (HCIP)
To identify the best performing strategy to filter the obtained AP-MS raw data we compared the receiver operator characteristics of
several established computational methods using published kinase protein interactions (reported by at least two references) and the
corresponding random set of protein interactions. We found that the weighted D (WD) score (Sowa et al., 2009) as well as spectral
count ratios corrected for false positive detection based on data from a large set of GFP control purifications outperformed the other
scores tested with respect to sensitivity and specificity (Figure S1A). We therefore combined WD score and spectral count ratios for
generating the final high-confidence protein interaction dataset. The chosen cutoff for theWD score and the spectral count ratios was
set to keep the number of false positive interactions below one percent as determined from the ROC curve while maximizing the re-
covery of already known PPI in the filtered data.
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, where xj was set to the minimum value > 0 of all interactors, if xj = 0.
Total spectral count values of identified co-purified proteins were compared to a control AP dataset consisting of 94 Strep HA-GFP
purification experiments, from which 68 GFP control datasets have been measured on an LTQ Orbitrap XL mass spectrometer and
deposited in the CRAPome contaminant repository for affinity purification (Mellacheruvu et al., 2013).
A custom R script was used to select an enrichment cut off over the control dataset (GFP-ratio) and a WD-score threshold, candi-
date bait-prey interactions were looked-up for literature references in the IntAct database (release date: 31.03.2015). Matches with at
least two publications were considered to be true positive hits. A corresponding number of true false hits was generated by permu-
tation of the prey and bait identifiers in the input Table 20 timeswith replacement and random sampling. TheWD-score andGFP-ratio
thresholds of 73.6 and 18.4, respectively, were selected by computation of receiver operating characteristic and selection of a FPR
threshold of 1%.
Only candidate interactions above the WD-score and GFP-ratio threshold were considered to be of high confidence. Additional
filtering criteria applied included removal of Keratins, adenoviral proteins, self-bait interactions, iRT peptides, obsolete entries and
interactions that had a total number of spectral count lower than 2. Finally, interactors present in more than 70%of the 411CRAPome
human control runs (v1.1) as well as residual carry-over proteins were removed from the filtered table.
Co-purification analysis
A local perl script was used to apply the hypergeometric test and calculate significance of co-purification for each of the protein pairs













m = Number of times two proteins are seen with the same kinase bait
k = Number of kinase baits protein 1 was purified with
l = Number of kinase baits protein 2 was purified with
N = Total number of kinase baits
The obtained values were adjusted for multiple testing using Benjamini-Hochberg correction. The most significant terms are de-
picted as a network and shown in Figure 2. Only the pair NUP188 – GCN1 is left out from the illustration. The reason for this is that
NUP18 is present in 25% of the studies in the CRAPome database and there is a risk it could be a non-specific binder.
Additional resources
Interaction data was deposited onto the following website:
https://sec-explorer.shinyapps.io/Kinome_interactions/.Molecular Cell 79, 504–520.e1–e9, August 6, 2020 e9
